2-Amino-6-ethoxybenzothiazoleCAS# 94-45-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 94-45-1 | SDF | Download SDF |
PubChem ID | 7192 | Appearance | Powder |
Formula | C9H10N2OS | M.Wt | 194.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 6-ethoxy-1,3-benzothiazol-2-amine | ||
SMILES | CCOC1=CC2=C(C=C1)N=C(S2)N | ||
Standard InChIKey | KOYJWFGMEBETBU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C9H10N2OS/c1-2-12-6-3-4-7-8(5-6)13-9(10)11-7/h3-5H,2H2,1H3,(H2,10,11) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2-Amino-6-ethoxybenzothiazole Dilution Calculator
2-Amino-6-ethoxybenzothiazole Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.1467 mL | 25.7334 mL | 51.4668 mL | 102.9336 mL | 128.667 mL |
5 mM | 1.0293 mL | 5.1467 mL | 10.2934 mL | 20.5867 mL | 25.7334 mL |
10 mM | 0.5147 mL | 2.5733 mL | 5.1467 mL | 10.2934 mL | 12.8667 mL |
50 mM | 0.1029 mL | 0.5147 mL | 1.0293 mL | 2.0587 mL | 2.5733 mL |
100 mM | 0.0515 mL | 0.2573 mL | 0.5147 mL | 1.0293 mL | 1.2867 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Benzyl nicotinate
Catalog No.:BCC8874
CAS No.:94-44-0
- Butylparaben
Catalog No.:BCN8418
CAS No.:94-26-8
- Tetracaine
Catalog No.:BCC9175
CAS No.:94-24-6
- Chlorpropamide
Catalog No.:BCC4647
CAS No.:94-20-2
- Benzyl 4-hydroxybenzoate
Catalog No.:BCC8869
CAS No.:94-18-8
- Sodium 4-amiropparaty Hyalrate
Catalog No.:BCC3855
CAS No.:94-16-6
- Propylparaben
Catalog No.:BCN8416
CAS No.:94-13-3
- Benzocaine
Catalog No.:BCC4636
CAS No.:94-09-7
- Synephrine
Catalog No.:BCN6308
CAS No.:94-07-5
- p53 and MDM2 proteins-interaction-inhibitor racemic
Catalog No.:BCC1831
CAS No.:939983-14-9
- RG7112
Catalog No.:BCC1894
CAS No.:939981-39-2
- p53 and MDM2 proteins-interaction-inhibitor chiral
Catalog No.:BCC1830
CAS No.:939981-37-0
- Piperine
Catalog No.:BCN1018
CAS No.:94-62-2
- N,N'-Bis(salicylidene)ethylenediamine
Catalog No.:BCC9064
CAS No.:94-93-9
- NVP-BHG712
Catalog No.:BCC3963
CAS No.:940310-85-0
- Suplatast Tosylate
Catalog No.:BCC4961
CAS No.:94055-76-2
- Poliumoside
Catalog No.:BCN1204
CAS No.:94079-81-9
- R-7128
Catalog No.:BCC1880
CAS No.:940908-79-2
- SB743921
Catalog No.:BCC4559
CAS No.:940929-33-9
- KD 5170
Catalog No.:BCC2420
CAS No.:940943-37-3
- 1'-Acetonaphthone
Catalog No.:BCC8446
CAS No.:941-98-0
- 1,3,5-Cadinatriene-3,8-diol
Catalog No.:BCN4486
CAS No.:941227-27-6
- Selaginellin
Catalog No.:BCN8215
CAS No.:941269-84-7
- Ruxolitinib (INCB018424)
Catalog No.:BCC1276
CAS No.:941678-49-5
In vitro and in vivo activity of new rhodium (III) complexes against Leishmania donovani.[Pubmed:11490204]
Pharmacology. 2001;63(2):112-9.
The activities of 17 new rhodium drug complexes were determined against Leishmania donovani promastigotes. The five most active salts were selected: [Rh(III)(2-Amino-6-ethoxybenzothiazole)(4)Br(2)](+)Br(-); [Rh(III)(2-bromothiazole)(4)(Br)(2)](+)Br(-); [Rh(III)(mefloquine)(4)(Cl)(2)](+)Cl(-); [Rh(III)(2-mepacrine)(4)(Cl)(2)](+)Cl(-), and [Rh(III)(oxamniquine)(4)(Cl)(2)](+)Cl(-), which induced growth-inhibition rates of more than 50% at 24 h of treatment and at the maximum dosage tested. The cytotoxicity assays on the macrophage cell line J-774 showed high cytotoxicity for the salts [Rh(III) (mefloquine)(4)(Cl)(2)](+)Cl(-), [Rh(III)(2-mepacrine)(4)(Cl)(2)](+)Cl(-) and [Rh(III)(oxaminquine)(4)(Cl)(2)](+)Cl(-) with a percentage of specific (15)Cr release of 49.3, 64.8 and 53.2% at 24 h of incubation and 100 microg/ml. Meanwhile, assays of the other compounds showed practically no cytotoxicity. The ultrastructural studies in the flagellates treated with the salt [Rh(III)(2-Amino-6-ethoxybenzothiazole)(4)Br(2)](+)Br(-) showed some alterations in the nucleus of the parasites with a very condensed chromatin and an electrodense endosome. This compound showed a high in vivo activity in parasitized Wistar rats.